G01N 2440/10
Acylation
Official title: acylation, e.g. acetylation, formylation, lipoylation, myristoylation, palmitoylation
G01N2440/10 (Acylation) appears on 33 US grants and 72 published applications in this corpus.
Search patents in G01N- Granted patents
- 33
- Published applications
- 72
- Assignees
- 55
- Inventors
- 147
- Latest grant
- 19 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 3 |
| 2013 | 0 | 3 |
| 2014 | 2 | 5 |
| 2015 | 0 | 11 |
| 2016 | 4 | 5 |
| 2017 | 1 | 5 |
| 2018 | 0 | 3 |
| 2019 | 2 | 6 |
| 2020 | 5 | 3 |
| 2021 | 2 | 6 |
| 2022 | 3 | 5 |
| 2023 | 2 | 6 |
| 2024 | 5 | 4 |
| 2025 | 3 | 3 |
| 2026 | 4 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Systems and methods for identifying subtype, prognosis, and monitoring of breast cancer19 May 2026US 12,631,640 B2Purdue Research Foundation
- Antibody for detecting acetylation of COX2 protein, and uses thereof5 May 2026US 12,618,840 B2Kyungpook National University Industry-Academic Cooperation Foundation
- Anti-MAA immunoglobulin isotypes in inflammatory bowel disease: novel diagnostic implications for ulcerative colitis10 Mar 2026US 12,571,795 B2Board of Regents of the University of Nebraska
- Liquid chromatography assay for determining AAV capsid ratio10 Mar 2026US 12,571,797 B2Regeneron Pharmaceuticals, Inc.
- Reagents and methods for detecting protein lysine 2-hydroxyisobutyrylation30 Dec 2025US 12,510,549 B2PTM Biolab Inc.
- Anti-maa immunoglobulin isotypes in inflammatory bowel disease: novel diagnostic implications for ulcerative colitis20 Aug 2026US 2026/0243763 A1Board of Regents of the University of Nebraska
- Methods of controlled cleavage2 Jul 2026US 2026/0185996 A1Quantum-Si Incorporated
- Methods and compositions for tauopathy diagnosis and treatment25 Sep 2025US 2025/0298039 A1Children's Medical Center Corporation
- Methods and systems for designing and/or characterizing soluble lipidated ligand agents5 Jun 2025US 2025/0179130 A1On Target Therapeutics LLC
- Methods for improving the efficacy of hdac inhibitor therapy and predicting the response to treatment with hdac inhibitor1 May 2025US 2025/0134952 A1Centre Hospitalier Regional Universitaire De Lille
Most cited
By later US patents
- Methods and systems for designing and/or characterizing soluble lipidated ligand agents4US 10,233,219 B2On Target Therapeutics LLC · 2019
- Vaccine engineering3US 9,289,488 B2AC Immune SA · 2016
- Circulating antibodies against MAA adducts as biomarker for coronary artery disease2US 10,591,468 B2Board of Regents of the University of Nebraska · 2020
- Method of analyzing post-translational modifications2US 10,712,254 B2Oxford University Innovation Limited · 2020
- Methods and systems for designing and/or characterizing soluble lipidated ligand agents2US 11,254,720 B2On Target Therapeutics LLC · 2022